Contact
Please use this form to send email to PR contact of this press release:
CoronaStem 1 Trial - Personalized Stem Cells Files for Expedited FDA Approval to Treat COVID-19 Patients
TO:
Michael Dale, President/COO
Personalized Stem Cells, Inc
+1 833-772-3557